Hypoalbuminaemia in the perioperative period: Clinical significance and management options

Dustin R. Neel, Stephen McClave, Robert Martindale

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Albumin has been the focus of literally thousands of articles since its first use in the clinical setting during World War II. Despite being at the centre of several clinical controversies, many questions still remain regarding the use and abuse of albumin. The major physiologic functions include maintaining colloid osmotic pressure, binding and transport of metabolically active molecules, serving as an antioxidant, use as a surrogate marker of nutritional status and predictor of outcome in elective surgical populations, having an anti-thrombotic influence on platelets, aiding in acid-base balance and having a protective influence on capillary membrane integrity. Albumin will continue to be widely used in clinical medicine despite many of the drawbacks. It now appears the benefits in the use of albumin in most cases outweigh the risks. The clinical implications of hypoalbuminaemia as an indicator of surgical or intensive care unit (ICU) outcome or nutritional status is clearly disease- and organ specific. The use of albumin as a volume expander appears to have limited, if any, benefit over crystalloid. The "secondary" benefits of albumin in specific surgical and intensive-care conditions, such as sepsis and organ dysfunction, are numerous and are well supported in the current literature.

Original languageEnglish (US)
Pages (from-to)395-400
Number of pages6
JournalBest Practice and Research: Clinical Anaesthesiology
Volume25
Issue number3
DOIs
StatePublished - Sep 2011

Fingerprint

Hypoalbuminemia
Perioperative Period
Albumins
Critical Care
Nutritional Status
World War II
Acid-Base Equilibrium
Active Biological Transport
Clinical Medicine
Osmotic Pressure
Colloids
Intensive Care Units
Sepsis
Blood Platelets
Antioxidants
Biomarkers
Membranes
Population

Keywords

  • albumin
  • antioxidant
  • capillary integrity
  • colloid osmotic pressure
  • hypoalbuminemia
  • surrogate nutrition indicator
  • volume expansion

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Hypoalbuminaemia in the perioperative period : Clinical significance and management options. / Neel, Dustin R.; McClave, Stephen; Martindale, Robert.

In: Best Practice and Research: Clinical Anaesthesiology, Vol. 25, No. 3, 09.2011, p. 395-400.

Research output: Contribution to journalArticle

@article{3d08cff4b07c4dc497ebe8d243c4c0df,
title = "Hypoalbuminaemia in the perioperative period: Clinical significance and management options",
abstract = "Albumin has been the focus of literally thousands of articles since its first use in the clinical setting during World War II. Despite being at the centre of several clinical controversies, many questions still remain regarding the use and abuse of albumin. The major physiologic functions include maintaining colloid osmotic pressure, binding and transport of metabolically active molecules, serving as an antioxidant, use as a surrogate marker of nutritional status and predictor of outcome in elective surgical populations, having an anti-thrombotic influence on platelets, aiding in acid-base balance and having a protective influence on capillary membrane integrity. Albumin will continue to be widely used in clinical medicine despite many of the drawbacks. It now appears the benefits in the use of albumin in most cases outweigh the risks. The clinical implications of hypoalbuminaemia as an indicator of surgical or intensive care unit (ICU) outcome or nutritional status is clearly disease- and organ specific. The use of albumin as a volume expander appears to have limited, if any, benefit over crystalloid. The {"}secondary{"} benefits of albumin in specific surgical and intensive-care conditions, such as sepsis and organ dysfunction, are numerous and are well supported in the current literature.",
keywords = "albumin, antioxidant, capillary integrity, colloid osmotic pressure, hypoalbuminemia, surrogate nutrition indicator, volume expansion",
author = "Neel, {Dustin R.} and Stephen McClave and Robert Martindale",
year = "2011",
month = "9",
doi = "10.1016/j.bpa.2011.07.006",
language = "English (US)",
volume = "25",
pages = "395--400",
journal = "Bailliere's Best Practice and Research in Clinical Anaesthesiology",
issn = "1521-6896",
publisher = "Bailliere Tindall Ltd",
number = "3",

}

TY - JOUR

T1 - Hypoalbuminaemia in the perioperative period

T2 - Clinical significance and management options

AU - Neel, Dustin R.

AU - McClave, Stephen

AU - Martindale, Robert

PY - 2011/9

Y1 - 2011/9

N2 - Albumin has been the focus of literally thousands of articles since its first use in the clinical setting during World War II. Despite being at the centre of several clinical controversies, many questions still remain regarding the use and abuse of albumin. The major physiologic functions include maintaining colloid osmotic pressure, binding and transport of metabolically active molecules, serving as an antioxidant, use as a surrogate marker of nutritional status and predictor of outcome in elective surgical populations, having an anti-thrombotic influence on platelets, aiding in acid-base balance and having a protective influence on capillary membrane integrity. Albumin will continue to be widely used in clinical medicine despite many of the drawbacks. It now appears the benefits in the use of albumin in most cases outweigh the risks. The clinical implications of hypoalbuminaemia as an indicator of surgical or intensive care unit (ICU) outcome or nutritional status is clearly disease- and organ specific. The use of albumin as a volume expander appears to have limited, if any, benefit over crystalloid. The "secondary" benefits of albumin in specific surgical and intensive-care conditions, such as sepsis and organ dysfunction, are numerous and are well supported in the current literature.

AB - Albumin has been the focus of literally thousands of articles since its first use in the clinical setting during World War II. Despite being at the centre of several clinical controversies, many questions still remain regarding the use and abuse of albumin. The major physiologic functions include maintaining colloid osmotic pressure, binding and transport of metabolically active molecules, serving as an antioxidant, use as a surrogate marker of nutritional status and predictor of outcome in elective surgical populations, having an anti-thrombotic influence on platelets, aiding in acid-base balance and having a protective influence on capillary membrane integrity. Albumin will continue to be widely used in clinical medicine despite many of the drawbacks. It now appears the benefits in the use of albumin in most cases outweigh the risks. The clinical implications of hypoalbuminaemia as an indicator of surgical or intensive care unit (ICU) outcome or nutritional status is clearly disease- and organ specific. The use of albumin as a volume expander appears to have limited, if any, benefit over crystalloid. The "secondary" benefits of albumin in specific surgical and intensive-care conditions, such as sepsis and organ dysfunction, are numerous and are well supported in the current literature.

KW - albumin

KW - antioxidant

KW - capillary integrity

KW - colloid osmotic pressure

KW - hypoalbuminemia

KW - surrogate nutrition indicator

KW - volume expansion

UR - http://www.scopus.com/inward/record.url?scp=80052985894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052985894&partnerID=8YFLogxK

U2 - 10.1016/j.bpa.2011.07.006

DO - 10.1016/j.bpa.2011.07.006

M3 - Article

C2 - 21925404

AN - SCOPUS:80052985894

VL - 25

SP - 395

EP - 400

JO - Bailliere's Best Practice and Research in Clinical Anaesthesiology

JF - Bailliere's Best Practice and Research in Clinical Anaesthesiology

SN - 1521-6896

IS - 3

ER -